TIAA CREF Investment Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
2017
Q4
$334K Sell
2017
Q3
$393K Buy
2017
Q2
$347K Buy
2016
Q2
Sell
2016
Q1
$402K Hold
2015
Q4
$702K Buy
2015
Q3
$729K Sell
2015
Q2
$1.14M Buy
2015
Q1
$451K Hold
2014
Q4
$526K Buy
2014
Q3
$492K Sell
2014
Q2
$859K Buy
2013
Q3
Sell
2013
Q2
$9K Buy